Recent Posts
- HealthInvest June 2026: A Look Inside Australia's Healthcare Innovations16 Jun 2026
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences19 May 2026
- Lifesaving Capital: How impact investing is shaping the future of biotech30 Apr 2026
- Investor Relations: the quiet advantage powering ASX microcaps28 Nov 2025
- HealthInvest Sydney: Life Sciences in the Investor Spotlight06 Oct 2025
Archives
Mosquito-borne diseases in Australia - an interview with Dr David Foster, CEO of Island Pharmaceuticals

We speak with Dr David Foster, CEO & Managing Director of Island Pharmaceuticals, about the current mosquito-borne diseases landscape in Australia. With recent outbreaks of dengue fever and Japanese encephalitis, should we be worried?
